{"id":"W3028188420","doi":"10.1016/j.jval.2020.04.1534","title":"PCN28 CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) IN HORMONE RECEPTOR-POSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC): A SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE (RWE) STUDIES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Palbociclib; Letrozole; Medicine; Fulvestrant; Metastatic breast cancer; Internal medicine; Oncology; Progression-free survival; Cyclin-dependent kinase 4; Cancer; Breast cancer; Aromatase; Gynecology; Estrogen receptor; Overall survival; Cyclin-dependent kinase 2; Cell cycle","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001712173,0.0008375773,0.003498074,0.0005794647,0.0001487395,0.0000279886,0.0003894305,0.0001284315,0.0001213321],"category_scores_gemma":[0.002194099,0.0007040874,0.0003022475,0.002765805,0.0003274654,0.0007760971,0.0001793523,0.001225427,0.00002183705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003020423,"about_ca_system_score_gemma":0.0008761961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003589822,"about_ca_topic_score_gemma":0.0004483917,"domain_scores_codex":[0.9910939,0.002235627,0.003249995,0.001224682,0.00120421,0.0009915385],"domain_scores_gemma":[0.9943554,0.001561371,0.001930214,0.0006616168,0.000869434,0.0006220007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.003235118,0.0009192264,0.01510452,0.9284425,0.0007359446,0.0003805418,0.02884326,0.0007163864,0.01239996,0.000427505,0.001071929,0.007723054],"study_design_scores_gemma":[0.004791731,0.001827507,0.02758405,0.9572154,0.0002216128,0.00009452595,0.002653039,0.0001340913,0.004241331,0.0002946112,0.00006964021,0.0008725033],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1690308,0.7847116,0.00006600754,0.03560651,0.0005749862,0.008795224,0.0009953736,0.0001750776,0.00004440625],"genre_scores_gemma":[0.5461816,0.4440576,0.003557981,0.004431884,0.0004089306,0.001034186,0.00005583785,0.0001447276,0.0001272942],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.3771508,"threshold_uncertainty_score":0.999541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06409227364805688,"score_gpt":0.3774474890229369,"score_spread":0.31335521537488,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}